Patents by Inventor Pär Ingemar JOHANSSON

Pär Ingemar JOHANSSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240241111
    Abstract: The present invention relates to a medicament for treatment of critically ill subjects with elevated levels of succinic acid, and a method of identifying patients likely to benefit from treatment with a medicament capable of inhibiting catecholamine release and/or blocking adrenergic receptors.
    Type: Application
    Filed: May 5, 2022
    Publication date: July 18, 2024
    Inventors: Pär Ingemar JOHANSSON, Hanne Hee HENRIKSEN
  • Patent number: 11714094
    Abstract: Use of prostacyclin or an analogue thereof for treatment of a new medical indication in acute critically ill patients, in particular acute critically ill patients with systemic endothelial damage, a biomarker for identifying individuals that have a new medical indication, and a method for identifying a new medical indication.
    Type: Grant
    Filed: January 3, 2020
    Date of Patent: August 1, 2023
    Assignee: Endothel Pharma ApS
    Inventors: Sisse Rye Ostrowski, Pär Ingemar Johansson
  • Publication number: 20200217857
    Abstract: Use of prostacyclin or an analogue thereof for treatment of a new medical indication in acute critically ill patients, in particular acute critically ill patients with systemic endothelial damage, a biomarker for identifying individuals that have a new medical indication, and a method for identifying a new medical indication.
    Type: Application
    Filed: January 3, 2020
    Publication date: July 9, 2020
    Inventors: Sisse Rye OSTROWSKI, Pär Ingemar JOHANSSON
  • Patent number: 10527633
    Abstract: Use of prostacyclin or an analogue thereof for treatment of a new medical indication in acute critically ill patients, in particular acute critically ill patients with systemic endothelial damage, a biomarker for identifying individuals that have a new medical indication, and a method for identifying a new medical indication.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: January 7, 2020
    Assignee: ENDOTHEL PHARMA APS
    Inventors: Sisse Rye Ostrowski, Pär Ingemar Johansson
  • Publication number: 20180246123
    Abstract: Use of prostacyclin or an analogue thereof for treatment of a new medical indication in acute critically ill patients, in particular acute critically ill patients with systemic endothelial damage, a biomarker for identifying individuals that have a new medical indication, and a method for identifying a new medical indication.
    Type: Application
    Filed: March 22, 2016
    Publication date: August 30, 2018
    Inventors: Sisse Rye OSTROWSKI, Pär Ingemar JOHANSSON
  • Publication number: 20180088131
    Abstract: Use of prostacyclin or an analogue thereof for treatment of a new medical indication in acute critically ill patients, in particular acute critically ill patients with systemic endothelial damage, a biomarker for identifying individuals that have a new medical indication, and a method for identifying a new medical indication.
    Type: Application
    Filed: March 22, 2016
    Publication date: March 29, 2018
    Inventors: Sisse Rye OSTROWSKI, Pär Ingemar JOHANSSON